×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ATHA – athira pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ATHA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
01:52 pm
atha
Athira Pharma, Inc. (ATHA) Discusses Acquisition of Rights to Lasofoxifene Phase III Program for Metastatic Breast Cancer Transcript [Seeking Alpha]
Low
Report
Athira Pharma, Inc. (ATHA) Discusses Acquisition of Rights to Lasofoxifene Phase III Program for Metastatic Breast Cancer Transcript [Seeking Alpha]
12/18
07:32 am
atha
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million [Yahoo! Finance]
Low
Report
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million [Yahoo! Finance]
12/18
07:02 am
atha
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million
High
Report
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million
11/6
04:05 pm
atha
Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
10/24
12:16 pm
atha
Athira Pharma (NASDAQ:ATHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Athira Pharma (NASDAQ:ATHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
03:48 pm
atha
Form SCHEDULE 13G/A Athira Pharma, Inc. Filed by: BML Investment Partners, L.P.
Low
Report
Form SCHEDULE 13G/A Athira Pharma, Inc. Filed by: BML Investment Partners, L.P.
12/18
08:25 am
atha
Form 8-K/A Athira Pharma, Inc. For: Dec 18
Low
Report
Form 8-K/A Athira Pharma, Inc. For: Dec 18
12/18
07:17 am
atha
Form 8-K Athira Pharma, Inc. For: Dec 18
Low
Report
Form 8-K Athira Pharma, Inc. For: Dec 18
11/14
04:09 pm
atha
Form SCHEDULE 13G Athira Pharma, Inc. Filed by: Baselake Partners, LP
Low
Report
Form SCHEDULE 13G Athira Pharma, Inc. Filed by: Baselake Partners, LP
11/6
04:15 pm
atha
Form 10-Q Athira Pharma, Inc. For: Sep 30
Medium
Report
Form 10-Q Athira Pharma, Inc. For: Sep 30
11/6
04:11 pm
atha
Form 8-K Athira Pharma, Inc. For: Nov 06
Medium
Report
Form 8-K Athira Pharma, Inc. For: Nov 06
10/10
04:41 pm
atha
Form SCHEDULE 13G/A Athira Pharma, Inc. Filed by: Oliveira Steven Michael
Low
Report
Form SCHEDULE 13G/A Athira Pharma, Inc. Filed by: Oliveira Steven Michael
10/3
09:11 am
atha
Form 8-K Athira Pharma, Inc. For: Oct 02
Low
Report
Form 8-K Athira Pharma, Inc. For: Oct 02
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: